Browsing BioMed Central høstingsarkiv by Author "Tacconelli, Evelina"

Now showing items 1-1 of 1

  • Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial 
    Trøseid, Marius; Arribas, José R.; Assoumou, Lambert; Holten, Aleksander R.; Poissy, Julien; Terzić, Vida; Mazzaferri, Fulvia; Baño, Jesús R.; Eustace, Joe; Hites, Maya; Joannidis, Michael; Paiva, José-Artur; Reuter, Jean; Püntmann, Isabel; Patrick-Brown, Thale D. J. H.; Westerheim, Elin; Nezvalova-Henriksen, Katerina; Beniguel, Lydie; Dahl, Tuva B.; Bouscambert, Maude; Halanova, Monika; Péterfi, Zoltán; Tsiodras, Sotirios; Rezek, Michael; Briel, Matthias; Ünal, Serhat; Schlegel, Martin; Ader, Florence; Lacombe, Karine; Amdal, Cecilie D.; Rodrigues, Serge; Tonby, Kristian; Gaudet, Alexandre; Heggelund, Lars; Mootien, Joy; Johannessen, Asgeir; Møller, Jannicke H.; Pollan, Beatriz D.; Tveita, Anders A.; Kildal, Anders B.; Richard, Jean-Christophe; Dalgard, Olav; Simensen, Victoria C.; Baldé, Aliou; de Gastines, Lucie; del Álamo, Marta; Aydin, Burç; Lund-Johansen, Fridtjof; Trabaud, Mary-Anne; Diallo, Alpha; Halvorsen, Bente; Røttingen, John-Arne; Tacconelli, Evelina; Yazdanpanah, Yazdan; Olsen, Inge C.; Costagliola, Dominique (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2023)
    Background Baricitinib has shown efficacy in hospitalized patients with COVID-19, but no placebo-controlled trials have focused specifically on severe/critical COVID, including vaccinated participants. ...